Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/2005
06/01/2005EP1534715A1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders
06/01/2005EP1534707A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
06/01/2005EP1534705A1 Process for preparing zolmitriptan compounds
06/01/2005EP1534700A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534334A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers
06/01/2005EP1534295A1 Formulations and methods of administration of cephalotaxines, including homoharringtonine
06/01/2005EP1534255A2 Processes for preparing 1,3-dioxolane nucleosides
06/01/2005EP1534074A2 Combination therapy for the treatment of obesity
06/01/2005EP1219626B1 Compounds for fluorescence labeling
06/01/2005CN1621406A Production process of camptothecin
06/01/2005CN1621038A Usage of glanthidine, total alkali extract and preparation method and usage thereof
06/01/2005CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same
05/2005
05/31/2005US6900341 Substituted phenylketoenols
05/31/2005US6900227 Benzodioxole derivatives
05/31/2005US6900220 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
05/31/2005US6900217 Substituted 6,5-hetero-bicyclic derivatives
05/31/2005US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
05/31/2005US6900158 High-molecular weight gel and display device
05/26/2005WO2005047526A2 Method for identifying inhibitors using a homology model of polo-like kinase 1
05/26/2005WO2005047252A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005WO2005046698A1 Fused heterocyclic compounds
05/26/2005WO2005046608A2 Novel compound, corresponding compositions, preparation and/or treatment methods
05/26/2005WO2005046588A2 Compounds, compositions, and methods
05/26/2005WO2005005600A3 Camptothecin analogs having an e-ring ketone
05/26/2005WO2004078851B1 Novel dyes and use thereof in thermal imaging members and methods
05/26/2005US20050113436 9-(4-Methylbenzyl)-6-[4-(trifluoromethoxy)phenyl]-1,9-dihydropyrano[3,4-b]indole-3,4-dione; treating fibrinolytic disorders, vein thrombosis and coronary heart disease, and pulmonary fibrosis
05/26/2005US20050113397 Broad spectrum antifungal agent; 1,6-beta-glucan synthetase inhibitors; pyrido(1,2-a)benzimidazole derivatives or benzo(4,5)imidazo(1,2-a)pyridine derivatives
05/26/2005US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders
05/26/2005US20050112781 4,7-dichlororhodamine dyes labeled polynucleotides
05/26/2005US20050112693 Screening, biosynthesis of peptides
05/26/2005CA2545876A1 Crystalline topotecan hydrochloride product and process for making the same
05/26/2005CA2545340A1 Fused heterocyclic compounds
05/26/2005CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005CA2543627A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
05/25/2005EP1533318A1 Prodrugs of thrombin inhibitors
05/25/2005EP1532980A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
05/25/2005EP1532153A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
05/25/2005EP1532132A1 Novel benzodioxoles
05/25/2005EP1531816A1 Spirocyclic piperidines as mch1 antagonists and uses thereof
05/25/2005EP1531811A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1203073C Novel process for producing fused imidazopridine derivative and crystal form
05/25/2005CN1203072C Pyranoindoles for treating alaucoma
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/25/2005CN1203061C Substituted isoquinolines, its preparing process, medical composition and its use for preparing medicine
05/24/2005US6897886 Indolylphthalide compound and thermal recording material using the same
05/24/2005US6897316 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents
05/24/2005US6897208 Protein kinase inhibitors
05/24/2005US6897200 Drug delivery a macromolecular complexes containing antitumor agent conjugated with a viral and non-viral RNA or vectors; stable, nonhydrolysis, gene therapy
05/24/2005CA2157289C Photochromic naphthopyran compounds
05/19/2005WO2005044822A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
05/19/2005WO2005044821A1 New camptothecin derivatives and processes of the preparation thereof and the use of the same
05/19/2005WO2005044820A1 Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents
05/19/2005WO2005044816A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
05/19/2005WO2005044796A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
05/19/2005WO2005044270A1 Oxadiazolopyrazine derivatives as pharmaceutically active compounds
05/19/2005WO2005044192A2 Triazole compounds and uses related thereto
05/19/2005WO2005044008A2 2 -aminothiophene compounds as fungicides
05/19/2005US20050107543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
05/19/2005US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors
05/19/2005US20050107419 E.g., Ethyl 2-[2-(4-fluorophenyl)ethyl]-4-(4-{[(2-furylmethyl)amino]carbonyl}phenyl)-5-oxo-8,9-dihydro-5H,7H-pyrazolo[1',2':1,2]pyrazolo[3,4-b]pyridine-3-carboxylate; analogous compounds based on the 7,8,9,9a-tetrahydro-5H-pyrido[2,3-a]pyrrolizine ring; osteoporous; bone disorders; osteoarthritis
05/19/2005US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators
05/19/2005US20050107365 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics
05/19/2005US20050104233 Method of substituent introduction through halogen-metal exchange reaction
05/19/2005US20050104042 Process for the synthesis of amine ethers from secondary amino oxides
05/19/2005CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
05/19/2005CA2544537A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
05/19/2005CA2543602A1 Triazole compounds and uses related thereto
05/18/2005EP1531166A2 Cycloaliphatic epoxy compounds containing styrenic, cinnamyl, or maleimide functionality
05/18/2005EP1531153A1 Epothilone derivatives
05/18/2005EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
05/18/2005EP1259484B1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
05/18/2005CN1617874A Hexacyclic compounds
05/18/2005CN1617865A Phenylalkynes
05/18/2005CN1617855A Inhibitors of cytosolic phospholipase A2
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1616460A Novel derivative of camptothecine, preparing method and use
05/18/2005CN1616446A Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring
05/18/2005CN1202108C Spiro compounds, preparing method and intermediate
05/17/2005US6894191 Reacting arylamine with aromatic halide in presence of catalyst and base
05/17/2005US6894047 Triazine compounds useful as sorbitol dehydrogenase inhibitors
05/17/2005US6894044 Treatment of depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, etc.
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893859 Antiproliferative agent for treating diseases or conditions characterized by cellular hyperproliferation
05/17/2005US6893668 Comprises of drying, grinding the plant, subjecting it to hot defatting with a light petroleum fraction followed by hot extraction with a solvent under vacuum to obtain crude extracts of the plant material, then precipitating and
05/17/2005US6892568 Noise detection system and method
05/17/2005CA2306782C Isoquinolines as urokinase inhibitors
05/17/2005CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones
05/12/2005WO2005042539A1 Tocopherol-modified therapeutic drug compounds
05/12/2005WO2005042538A1 Spirofuropyridine aryl derivatives
05/12/2005WO2005042528A1 Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
05/12/2005WO2005042526A1 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
05/12/2005WO2005041957A1 Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
05/12/2005WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005US20050101661 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 298